<DOC>
	<DOCNO>NCT02076685</DOCNO>
	<brief_summary>To improve treatment outcome patient tuberculosis integrate pharmacogenetics clinical practice , information NAT2 genotyping use re-challenge protocol isoniazid ( INH ) titration patient anti-tuberculosis medication-induced hepatitis .</brief_summary>
	<brief_title>NAT2 Genotyping Re-challenge Protocol INH Titration Patients With Anti-TB Medications-induced Hepatitis</brief_title>
	<detailed_description />
	<mesh_term>Isoniazid</mesh_term>
	<criteria>1 . &gt; = 18 year . 2 . Take INH least week . 3. abnormal liver function ( ALT ( alanine , transaminase ) increase three time upper limit normal , ALT high twice upper limit normal total bilirubin high 2.0 mg / dL 1.Taking INH liver function abnormality . 2 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>pharmacogenetics</keyword>
	<keyword>anti-tuberculosis drug</keyword>
	<keyword>genetic polymorphism</keyword>
	<keyword>isoniazid</keyword>
</DOC>